Eli Lilly (NYSE: $LLY) reached a $1 trillion market valuation, marking a historic moment for the global health-care industry. The company trades around $1,048 per […]
Category: Healthcare
Community Health Systems (NYSE: $CYH) Soars 18%+ After It Reports Q3 2025 Earnings: Is CYH A Buy?
Community Health Systems (NYSE: $CYH) is the largest provider of general hospital healthcare services in the US when it comes to the number of acute […]
AstraZeneca (NASDAQ: $AZN) Releases Q1 Fiscal 2025 Results: Is This Pharma Stock A Great Buy After Its Q1 Results?
AstraZeneca (NASDAQ: $AZN) posted its Q1 2025 earnings on April 29. The stock trades at $70.13. Revenue for the quarter rose 10% year-over-year to $13.59 […]
UnitedHealth Group (NYSE: $UNH) Drops 22%+ After Q1 Earnings Miss and 2025 Guidance Cut
UnitedHealth Group (NYSE: $UNH) reported its first-quarter 2025 earnings, but the results and revised guidance disappointed investors. As of 12:47 PM EDT, the stock was […]
Abbott Laboratories (NYSE: $ABT) Releases Q1 Fiscal 2025 Results: Is ABT a Buy Amid Macroeconomic Headwinds?
Abbott Laboratories (NYSE: $ABT) announced Q1 fiscal 2025 results on Wednesday, April 16th. The healthcare firm posted $1.33 billion in net income. Adjusted earnings reached […]
Johnson & Johnson (NYSE: JNJ) Releases Q1 Fiscal 2025 Results: Is This Dividend Stock Still a Buy Amid Tariff Fears?
Johnson & Johnson (NYSE: $JNJ), a major multinational that produces medical devices and pharmaceuticals, released its first-quarter fiscal 2025 results on Tuesday, April 15, 2025, […]